Suicidal ideation during treatment of depression with escitalopram and nortriptyline in Genome-Based Therapeutic Drugs for Depression (GENDEP): a clinical trial

Abstract

BACKGROUND Suicidal thoughts and behaviours during antidepressant treatment, especially during the first weeks of treatment, have prompted warnings by regulatory bodies. The aim of the present study is to investigate the course and predictors of emergence and worsening of suicidal ideation during tricyclic antidepressant and serotonin reuptake inhibitor… (More)
DOI: 10.1186/1741-7015-7-60

Topics

5 Figures and Tables

Cite this paper

@article{Perroud2009SuicidalID, title={Suicidal ideation during treatment of depression with escitalopram and nortriptyline in Genome-Based Therapeutic Drugs for Depression (GENDEP): a clinical trial}, author={Nader Ali Perroud and Rudolf Uher and Andrej Maru{\vs}i{\vc} and Marcella Rietschel and Ole N Mors and N Henigsberg and Joanna Hauser and Wolfgang Maier and Daniel Souery and Anna S Placentino and Aleksandra Szczepankiewicz and Lisbeth Jorgensen and Jana Strohmaier and A. Zobel and Caterina Giovannini and Amanda Elkin and Cerisse Gunasinghe and Joanna M Gray and Desmond D Campbell and Bhanu Gupta and Anne Farmer and Peter McGuffin and K Aitchison}, journal={BMC Medicine}, year={2009}, volume={7}, pages={60 - 60} }